MedStar Heart & Vascular Institute First to Implant Device in Clinical Trial | MedStar Health

MedStar Heart and Vascular Institute First to Implant Device in Clinical Trial

Share this
The clinical trial is investigating a potentially life-changing device proven to reduce the risk of stroke in certain patients with atrial fibrillation. The device, called the WATCHMAN FLX™, is being investigated for greater flexibility and safety while positioning the device in the left atrial appendage. Read more.